Investigating the tumor-related mechanisms of PTBP1 is essential, as dysregulation in its expression has been involved in disease promotion, including colorectal cancer invasion, breast and ovarian cancer cell growth, and Parkinson’s disease [37,38,39,40]. This evidence concerns the gene PTBP1 and ovarian carcinoma.